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P1 THE NINFEA PROJECT: ONE YEAR OF WORK
L. Giannotta, D. Falciatore1, F. Piccolantonio, L. Ratclif2. 1Family doctor, Italy;
2U.O.S. Cystic Fibrosis Cerignola, Italy
The NINFEA project has been established as a system of communication between
Cerignola and the family doctors in the area. The aim of the project consists on
providing to the patient a two-way assistance (hospital and family doctors). In this
way there is a sort of continuity in the patient’s care, which makes treatment of the
illness more adequate for him and his family.
The project has started after a specialization course on cystic ﬁbrosis consisting of
six meetings held monthly.
According to the project, the family doctor should do: monthly ﬁrst-aid visits
planned for the evaluation of the patient, and house visits in case the illness gets
worse. At the end of the visit the doctor sends via internet to the support Service
and to all the other doctors involved in the project (newsgroup), a form containing
the necessary anonymous data.
The project involves eighteen doctors caring for thirty-two patients affected with
cystic ﬁbrosis, three of whom were diagnosed during the ten months of NINFEA
activity.
In order to evaluate the effectiveness of the project, we have made a sort of quality
comparison between quality indicators, decided by comparing the ten activity
months (December 2006-September 2007) with the ten months of hospital activity
preceding the beginning of NINFEA (February-November2006).
The results are the following:
– The number of visits made by the hospital service has decreased from 258 to 78;
– Visits made from the doctors of NINFEA area: 266;
– The total n. of hospitalization days has decreased from 79 to 26;
– The total n. of days providing an antibiotical therapy has increased from 156 to
257;
– The complications set in have decreased from 2 to 0.
Moreover we have submitted the same questionnaire before the beginning of and a
year after the project to the 16 involved families, to which other 3 have added, for
a total of 19 families. Here is a list of the results:
• Satisfaction for the job made by the doctor in controlling the illness (before and
after NINFEA project):
– “not satisﬁed” from 68% to 3%;
– “poorly satisﬁed” from 27% to 5%;
– “enough satisﬁed” from 5% to 70%
– “very satisﬁed” from 0% to 22%.
• Do you feel now safer about the management and the control of the illness?
yes = 79%; no = 21%;
• Do you think there was an improvement in the way of treating the illness? yes =
85.5%; no = 14.5%.
These results show a clear improvement of patient management and support the
cooperation between the hospital and the area in treatment of Cystic Fibrosis.
P2 PROLONGING THE DURATION OF PERIPHERAL VENOUS
CATHETERS IN CYSTIC FIBROSIS PATIENTS. RANDOMIZED
CONTROLLED STUDY ON THE EFFECT OF DIFFERENT
CONCENTRATIONS OF ANTIBIOTICS IN NORMAL SALINE
F. Festini, S. Neri, G. Taccetti, T. Repetto, C. Braggion. Centro FC della Toscana,
Ospedale Meyer, Universita` di Firenze, Florence, Italy
Background: Patients with CF frequently have to undergo IV antibiotic courses.
Peripherally inserted indwelling devices (PVC) are used to reduce the number of
venipunctures. The irritating action of antibiotics may interrupt the vein’s patency,
requiring numerous venipunctures to a patient to complete a course of antibiotic
treatment, which usually lasts 2 weeks, causing further suffering, pain and anxiety.
With the passing of time veins become difﬁcult to ﬁnd and the completion of a
course may become a problem and cause suffering to the patient.
An alternative to PVC are Central Venous Catheters but such an invasive interven-
tion may not be indicated due to patients’ clinical conditions.
A preliminary cohort study was carried out (Festini, Assist Inferm Ric
2005;24:91−6) which showed a correlation between the number of daily antibiotic
infusions and the duration on site of PVCs, suggesting that a higher dilution of
antibiotic may reduce its irritating action on the vein.
Goal: To investigate whether, administering the prescribed IV antibiotic with an
increased dilution in Normal Saline, it is possible to reduce the irritation on the
vein, reduce the risk of phlebitis and prolong the duration of the PVC, therefore
reducing the number of venipunctures needed to complete an antibiotic course.
Subjects and methods: Non blinded RCT, carried out at the CF Center of Tuscany,
Italy. CF adult subjects are recruited, to whom a 2-week IV antibiotic course with
ceftazidime and tobramycin is prescribed due to exacerbation.
Results: The recruitment started in March 2007. So far 6 patients were eligible
for the study and 4 were included. 2 were randomly assigned to group A – normal
antibiotic dilution – and 2 to group B – higher antibiotic dilution. Preliminary
results and interim analysis show that in Group A, the mean duration of PVCs was
3.75 days (SD 0.75), whereas in Group B, the mean duration of PVCs was 6.45
days (SD 0.07), T-test: p = 0.009. No statistically signiﬁcant differences resulted
with regard to phlebitis, inﬁltration and pain scores.
Discussion: Preliminary data seem to conﬁrm that an increased dilution of antibiotic
in NS may lead to increase the duration on site of PVCs. However, no conclusion
can be drawn so far. The study will continue until the end of 2008. If the hypothesis
is conﬁrmed, an easy, safe and economic method will be available to reduce the
number of venipunctures needed to complete an IV antibiotic course.
CDC/FDA/NIH Clinical Trial Registry n. NCT00418470. FFC Grant 19/2006
P3 HOME INTRAVENOUS ANTIBIOTIC THERAPY IN CYSTIC FIBROSIS
PATIENTS
C. Zappa, A. Raimondi. Centro di Riferimento per la Fibrosi Cistica Regione
Lombardia, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e
Regina Elena, Milan, Italy
Patients with Cystic Fibrosis (CF) suffer from progressive pulmonary disease with
recurrent exacerbations requing intravenous antibiotic therapy. Since 1996 the CF
Center of Lombardia Region accomplished a welfare service to provide patients an-
tibiotic treatments directly at home. This is achieved by means of an agreement with
ONLUS institutions. This experience increased in recent years, thanks to a growing
spread of welfare home services (ADI) to frail people (DGR 12902/09.05.2003
“Voucher Socio-Sanitario sul Territorio Lombardo”). This is a service consisting of
high to middle attendance in order to keep patients in their everyday environment as
long as possible as well as to avoid improper hospitalisation. However, home intra-
venous therapy is always dependent on medical, individual and family conditions.
Over one year period, a total of 167 home treatments were accomplished: 102
patients (44 males, mean age 23.5 years, range 14 months–4 years, 73% adults).
Home intravenous antibiotic therapy was applied to 65 patients who needed a single
cycle of intravenous therapy per year and 37 patients who needed multiple cycles
per year. Home intravenous antibiotic therapy was managed directly by patients or
their relatives in 64% of cases, by local services with the family’s support in 31.2%
of cases, while only 4.8% of cases were managed exclusively by domiciliary local
services. Treatments made at home covered 73% of the whole treatment time; only
5% of patients kept their complete daily activities and relationships such as school
or job. Furthermore, 10 patients, 8 of whom were adults, had the entire treatment
without a single day of hospitalization. Home intravenous antibiotic therapy was
effective in 96% of cases, with a signiﬁcant improvement, in FEV1 from baseline
to end of treatment values. Complications were scarce and of minor importance.
We conclude that home intravenous antibiotic therapy was very useful, well tolerated
as well as economically opportune.
P4 THE CAIRO PROJECT (COMPARATIVE ANALYSIS OF
INTERNATIONAL CF REGISTRIES OVERVIEWED): ANALYSIS AND
REVIEW OF THE SCIENTIFIC LITERATURE FROM CF REGISTRIES
D. Salvatore, E. Baldo, M.P. Forneris, M.L. Furnari, V. Lucidi, D. Manunza,
I. Marinelli, B. Messore, A.S. Neri, V. Raia, R. Buzzetti, G. Mastella. Italian
CF Research Foundation, Verona, Italy
Scientiﬁc literature based on CF registries worldwide was reviewed with the aim
of evaluating what main topics were carried out and which clinical questions
were answered. The search strategy started from (1) Medline and Embase using
“Cystic ﬁbrosis”[MESH] AND (“Registry”[MESH]) OR registr$) as search terms;
(2) Direct information from the CF registries; it was updated to the 30/06/07.
Inclusion criteria were: primary studies which starting from a Registry utilized
data drawn from that Registry to verify research hypothesis. 107 articles were
selected by 2 independent assessors on the basis of their pertinence. Articles were
examined with a form evaluating skills of different Registry data, selected clinical
characteristics of the study populations and statistical methods. Studies were from
USA-CFF (45%), Canada (2%), UK (13%), France (13%), Italy (3%), Germany
(3%), and other European Registries. A set of articles came from the ESCF-USA
study (11%). The main focuses of the articles were: (1) Incidence/prevalence and
survival (27 studies); (2) neonatal screening, growth and nutrition (23); (3) Clinical
genetics (15); (4) complications and outcomes (ABPA, CFRD, pregnancy etc) (35);
(5) microbiology (7).
Main results are: (1) Increasing survival accounts for speciﬁc prognostic factors
(2) Incidence rates are very variable in different countries (3) Genotype/phenotype
studies conﬁrm the severity of F508del mutation and the role of class mutation
(4) Newborn screening conﬁrms beneﬁts on growth and morbidity, but effect on
lung disease and survival is still far to demonstrate (5) There is no consensus on
correct deﬁnition of malnutrition (6) The pregnancy is an increasing event with
positive outcomes (7) Increasing prevalence of complications with age and their
